ANDREUCCI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 3.001
EU - Europa 2.582
AS - Asia 2.022
SA - Sud America 282
AF - Africa 45
OC - Oceania 24
Totale 7.956
Nazione #
US - Stati Uniti d'America 2.955
PL - Polonia 782
RU - Federazione Russa 738
CN - Cina 575
IT - Italia 476
SG - Singapore 466
HK - Hong Kong 274
BR - Brasile 214
VN - Vietnam 201
KR - Corea 162
IE - Irlanda 136
FI - Finlandia 102
BD - Bangladesh 82
IN - India 77
SE - Svezia 71
FR - Francia 60
DE - Germania 58
GB - Regno Unito 53
ID - Indonesia 43
JO - Giordania 41
JP - Giappone 30
CA - Canada 25
AR - Argentina 23
AU - Australia 22
NL - Olanda 19
CH - Svizzera 18
BE - Belgio 14
EC - Ecuador 14
ZA - Sudafrica 14
ES - Italia 12
AT - Austria 10
CZ - Repubblica Ceca 10
MX - Messico 8
PK - Pakistan 8
TR - Turchia 8
UA - Ucraina 8
CI - Costa d'Avorio 7
CL - Cile 7
CO - Colombia 7
TH - Thailandia 7
UZ - Uzbekistan 7
EG - Egitto 6
NG - Nigeria 6
PH - Filippine 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
IL - Israele 4
IQ - Iraq 4
JM - Giamaica 4
UY - Uruguay 4
VE - Venezuela 4
DO - Repubblica Dominicana 3
KZ - Kazakistan 3
MA - Marocco 3
MO - Macao, regione amministrativa speciale della Cina 3
MY - Malesia 3
PE - Perù 3
SY - Repubblica araba siriana 3
BJ - Benin 2
CR - Costa Rica 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
NZ - Nuova Zelanda 2
SN - Senegal 2
TN - Tunisia 2
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KW - Kuwait 1
MT - Malta 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
TW - Taiwan 1
Totale 7.956
Città #
Warsaw 782
Santa Clara 647
Ashburn 459
Singapore 377
Hong Kong 237
Fairfield 214
Seoul 161
San Jose 160
Hefei 154
Chandler 147
Dublin 136
Florence 107
Beijing 104
Seattle 85
Woodbridge 80
Houston 73
Helsinki 61
Ho Chi Minh City 60
Cambridge 59
Wilmington 59
Milan 54
Council Bluffs 51
Los Angeles 48
Ann Arbor 46
Buffalo 43
Moscow 43
Hanoi 40
Lauterbourg 38
Altamura 35
Lawrence 35
New York 35
Jakarta 33
Dallas 32
Kent 31
The Dalles 31
Dong Ket 30
Rome 30
Munich 29
Princeton 29
Shanghai 26
Boston 23
Turku 23
Pune 21
Mumbai 20
São Paulo 19
Tokyo 19
Melbourne 17
Clifton 16
London 16
Lappeenranta 14
Boardman 13
Phoenix 13
Pisa 13
San Diego 13
Naples 12
Shenzhen 12
Falls Church 11
Bengaluru 10
Bern 10
Bologna 10
Guangzhou 10
Orem 10
Chennai 9
Chicago 9
Turin 9
Medford 8
Redondo Beach 8
Tianjin 8
West Jordan 8
Abidjan 7
Da Nang 7
Frankfurt am Main 7
Montreal 7
Tashkent 7
Toronto 7
Vienna 7
Abuja 6
Amsterdam 6
Arezzo 6
Bangkok 6
Bari 6
Brescia 6
Brussels 6
Gavirate 6
New Delhi 6
Paris 6
Rio de Janeiro 6
Atlanta 5
Bratislava 5
Catania 5
Denver 5
Fortaleza 5
Ghent 5
Guayaquil 5
Haiphong 5
Hillsboro 5
Johannesburg 5
Lahore 5
Manchester 5
Norwalk 5
Totale 5.465
Nome #
Acidity of Microenvironment as a Further Driver of Tumor Metabolic Reprogramming 413
The acidic microenvironment as a possible niche of dormant tumor cells 322
EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells 292
Type II CRISPR/Cas9 approach in the oncological therapy 290
Anoikis resistance as a further trait of acidic-adapted melanoma cells 281
A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer 266
Oleuropein, the Main Polyphenol of Olea europaea Leaf Extract, Has an Anti-Cancer Effect on Human BRAF Melanoma Cells and Potentiates the Cytotoxicity of Current Chemotherapies 261
Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma 259
SOX2 as a novel contributor of oxidative metabolism in melanoma cells 253
The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells 251
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts 230
Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis 207
Everolimus selectively targets vemurafenib resistant BRAFV600E melanoma cells adapted to low pH 204
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 204
Local modulation of thyroid hormone signaling in the retina affects the development of diabetic retinopathy 182
An Oleocanthal-Enriched EVO Oil Extract Induces the ROS Production in Gastric Cancer Cells and Potentiates the Effect of Chemotherapy 180
The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs 179
Potential Role of HLA Class I Antigens in the Glycolytic Metabolism and Motility of Melanoma Cells 179
FDG uptake in cancer: a continuing debate 178
Blockade of Sialylation with Decrease in Polysialic Acid Levels Counteracts Transforming Growth Factor β1-Induced Skin Fibroblast-to-Myofibroblast Transition 177
The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells 177
Extracellular lactic acidosis drives reprogramming of human subcutaneous adipocytes toward pathogenic myofibroblasts 174
Nintedanib-Containing Dual Conjugates Targeting αVβ6 Integrin and Tyrosine Kinase Receptors as Potential Antifibrotic Agents 174
Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts 172
uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells 168
Skin telocyte secretome as conditioned medium prevents profibrotic differentiation of skin fibroblasts into myofibroblasts 164
Fenotipo Turner associato ad una delezione interstiziale sul braccio lungo del cromosoma 2 162
CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines 159
uPAR knockout results in a deep glycolytic and OXPHOS reprogramming in melanoma and colon carcinoma cell lines 158
FGF2 in Human Melanoma Progression: The Antithetical Functions of Different Isoforms 155
Pharmacological Stimulation of Soluble Guanylate Cyclase Counteracts the Profibrotic Activation of Human Conjunctival Fibroblasts 154
Enhanced vasculogenic capacity induced by 5-fluorouracil chemoresistance in a gastric cancer cell line 148
Extracellular Acidosis Differentially Regulates Estrogen Receptor β-Dependent EMT Reprogramming in Female and Male Melanoma Cells 147
Nintedanib-αVβ6 Integrin Ligand Conjugates Reduce TGFβ-Induced EMT in Human Non-Small Cell Lung Cancer 131
miR-214-enriched extracellular vesicles released by acid-adapted melanoma cells promote inflammatory macrophage-dependent tumor trans-endothelial migration 128
Blockade of sialylation with decrease in polysialic acid levels counteracts transforming growth factor β1-induced skin fibroblast-to-myofibroblast transition 126
Unraveling the Potential of Amino-, Acylamino-, and Ureido-Substituted 3H-1,2-Benzoxaphosphepine 2-Oxides toward Nanomolar Inhibitors of Tumor-Associated Carbonic Anhydrases IX and XII 116
uPAR controls vasculogenic mimicry ability expressed by drug-resistant melanoma cells. 113
Oleuropein affects braf melanoma cells and potentiates chemotherapy cytotoxicity 109
Skin Telocyte Secretome as Conditioned Medium Prevents Profibrotic Differentiation of Skin Fibroblasts into Myofibroblasts 108
Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry 105
Oleuropein potentiates the cytotoxic activity of dacarbazine against melanoma cells. 98
Ketoconazole-carbonic anhydrase inhibitors as potential anticancer agents 55
Discovery of First-in-Class Carbonic Anhydrase/Histone Deacetylase Dual Inhibitors with Antiproliferative Activity in Cancer Cells 27
Totale 8.036
Categoria #
all - tutte 21.404
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022231 25 39 8 8 8 14 7 15 7 22 32 46
2022/2023626 46 111 35 47 42 106 73 44 81 7 18 16
2023/2024426 3 29 33 17 21 66 28 106 12 43 32 36
2024/20252.115 64 189 168 343 571 238 37 165 61 41 120 118
2025/20263.015 296 444 324 329 269 92 355 147 188 186 133 252
2026/202711 11 0 0 0 0 0 0 0 0 0 0 0
Totale 8.036